Literature DB >> 2207402

Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.

J Taylor1, R A Mactier, W K Stewart, I S Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207402      PMCID: PMC1663757          DOI: 10.1136/bmj.301.6750.476

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Dialysis in the management of the renal failure of myeloma.

Authors:  N P Mallick
Journal:  Q J Med       Date:  1989-10

2.  Identification of tissues and cells producing erythropoietin in the anemic mouse.

Authors:  C Lacombe; J L Da Silva; P Bruneval; J P Camilleri; J Bariety; P Tambourin; B Varet
Journal:  Contrib Nephrol       Date:  1988       Impact factor: 1.580

3.  Anaemia in patients with myelomatosis.

Authors:  W C Ting; I Cavill; A Jacobs; S Kaaba; A May; S Smith; J A Whittaker
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

  3 in total
  5 in total

1.  Effect of erythropoietin in patients with myeloma.

Authors:  S Rogers; N H Russell; A G Morgan
Journal:  BMJ       Date:  1990-09-29

Review 2.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 3.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

4.  Increased plasma viscosity as a reason for inappropriate erythropoietin formation.

Authors:  A Singh; K U Eckardt; A Zimmermann; K H Götz; M Hamann; P J Ratcliffe; A Kurtz; W H Reinhart
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

5.  The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.

Authors:  B Joiner; V K Hirst; S R McKeown; J J McAleer; D G Hirst
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.